R. C. Turner - Concepedia

Author

R. C. Turner

Oxford Centre for Diabetes, Endocrinology and Metabolism

Also Known As

D BARRACLOUGH, R C TURNER, R C Turner, R TURNER, R Turner, R. C. TURNER, R. C. Turner, R. R. Holman, R. Turner, R.B. Turner

283

Publications

51K

Citations

H-Index

229

Concepts

All Affiliations

Oxford Centre for Diabetes, Endocrinology and Metabolism University of Oxford John Radcliffe Hospital

About

R. C. Turner is an author at Oxford Centre for Diabetes, Endocrinology and Metabolism specializing in medicine, diabetes, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	82	47K
2	Health Sciences	25	40	34.4K
3	Engineering	18	31	1K
4	Business	1	1	14
5	Language Studies	1	1	36

R. C. Turner

152

Publications

50.2K

Citations

H-Index

Page 1

	Year	Citations
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man David R. Matthews, J P Hosker, A. Rudenski, Diabetologia Insulin ResistanceObesityMetabolic SyndromeBody CompositionHealth Sciences	1985	31K
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. R. C. Turner, Charles Fox, Matthews, The Lancet Metabolic SyndromeDiabetes ManagementDiabetes EpidemiologyInsulin ManagementDiabetes	1998	8.4K
UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis Irene Stratton, Eva M. Kohner, S J Aldington, Diabetologia Diabetic RetinopathyOcular DiseaseDiabetes EpidemiologyOphthalmologyDiabetes	2001	1K
A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44) Rury R. Holman, C A Cull, R. C. Turner Diabetes Care	1999	445
UKPDS 26: sulphonylurea failure in non-insulin-dependent diabetic patients over six years R. C. Turner Diabetic Medicine Metabolic SyndromeDiabetes ManagementUrologyInsulin ManagementDiabetes	1998	436
Cyclic Oscillations of Basal Plasma Glucose and Insulin Concentrations in Human Beings D. Lang, David R. Matthews, Julian Peto, New England Journal of Medicine Insulin RiseHomeostatic MechanismBasal Plasma GlucoseInsulin SignalingMetabolic Syndrome	1979	404
Insulin deficiency and insulin resistance interaction in diabetes: Estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations R. C. Turner, Rury R. Holman, David R. Matthews, Metabolism ObesityMetabolic SyndromeInsulin ResistanceInsulin DeficiencyBody Composition	1979	389
Linkage of type 2 diabetes to the glucokinase gene Andrew T. Hattersley, R. C. Turner, P Patel, The Lancet GeneticsDiabetesGenetic EpidemiologyType 2Diabetes Mellitus	1992	387
ISLET AMYLOID FORMED FROM DIABETES-ASSOCIATED PEPTIDE MAY BE PATHOGENIC IN TYPE-2 DIABETES Anne Clark, Claire E. Lewis, A.C. Willis, The Lancet Autoimmune DiseaseDiabetesImmunologyPathologyProtein Misfolding	1987	356
Continuous infusion of glucose with model assessment: measurement of insulin resistance and ?-cell function in man J P Hosker, David R. Matthews, A. Rudenski, Diabetologia Insulin ResistanceMetabolic SyndromeDiabetes ManagementBody CompositionInsulin Management	1985	286

Page 1